Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Events entities : Ionis pharmaceuticals, inc. save search
Positive olezarsen Phase 3 data in familial chylomicronemia syndrome to be presented at 2024 American College of Cardiology (ACC) annual meeting
Published: 2024-03-25 (Crawled : 13:30) - biospace.com/
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: -0.14%
H: 3.12%
C: 2.93%
positive meeting cardiology
Ionis to present at upcoming investor conferences - March 28, 2023
Published: 2023-03-28 (Crawled : 12:20) - biospace.com/
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: -0.53%
H: 2.44%
C: 2.24%
Ionis to present at upcoming investor conferences - February 28, 2023
Published: 2023-02-28 (Crawled : 14:00) - biospace.com/
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: -0.5%
H: 1.61%
C: -0.36%
Ionis to host 2022 virtual Annual Meeting of Stockholders
Published: 2022-05-02 (Crawled : 12:00) - biospace.com/
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: -2.88%
H: 4.92%
C: 4.81%
Ionis to hold first quarter 2022 financial results webcast
Published: 2022-04-20 (Crawled : 12:00) - biospace.com/
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: 0.15%
H: 5.22%
C: 5.06%
results
Biogen Announces New Updates Across its SMA Research Program at 2022 MDA Conference
Published: 2022-03-14 (Crawled : 13:30) - biospace.com/
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: -1.82%
H: 3.59%
C: 3.4%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.47%
H: 1.48%
C: -2.43%
program research conference
Ionis to hold third quarter 2021 financial results webcast
Published: 2021-10-20 (Crawled : 20:00) - biospace.com/
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: 0.06%
H: 0.99%
C: -2.49%
financial results results
Ionis to host ATTR symposium highlighting CARDIO-TTRansform Study at 3rd European ATTR Amyloidosis meeting
Published: 2021-09-03 (Crawled : 12:00) - biospace.com/
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: -0.12%
H: 0.02%
C: -2.42%
europe cardio symposium
Ionis to present at upcoming virtual investor conferences - Sep 02, 2021
Published: 2021-09-02 (Crawled : 12:00) - biospace.com/
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: 0.67%
H: 0.48%
C: -0.17%
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: 0.55%
H: 0.52%
C: 0.12%
conference
Ionis announces changes to its board of directors at annual meeting of stockholders
Published: 2021-06-03 (Crawled : 10:00) - biospace.com/
LPTX | $2.81 -5.07% -5.34% 200K
|
Health Technology
|
| O: -0.62%
H: 1.86%
C: 0.0%
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: -0.39%
H: 1.18%
C: -2.31%
BLSA | $10.035 0.0%
|
Finance
|
| O: -0.58%
H: 0.78%
C: 0.78%
Ionis to present at upcoming investor conferences - Mar 26, 2021
Published: 2021-03-26 (Crawled : 12:00) - biospace.com/
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: 0.61%
H: 0.7%
C: 0.42%
conference presentation
Ionis to hold 2020 financial results webcast
Published: 2021-02-11 (Crawled : 13:00) - biospace.com/
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: 0.31%
H: 0.55%
C: -0.55%
financial results results
Ionis to participate in virtual fireside chat at BMO 2020 Growth and ESG conference
Published: 2020-12-02 (Crawled : 17:00) - biospace.com/
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: 0.68%
H: 0.72%
C: -0.31%
growth
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.